Serkan Demir

Sancaktepe, 34785, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Corrigendum to "Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study" [Multiple Sclerosis and Related Disorders, Volume 97 (2025): 106383].

Corrigendum to "Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study" [Multiple Sclerosis and Related Disorders, Volume 97 (2025): 106383].

Journal: Multiple sclerosis and related disorders

Published: September 07, 2026

Respiratory Muscle Performance and Pulmonary Function in Sarcopenic and Non-Sarcopenic Patients with Multiple Sclerosis: A Cross-Sectional Study.

Respiratory Muscle Performance and Pulmonary Function in Sarcopenic and Non-Sarcopenic Patients with Multiple Sclerosis: A Cross-Sectional Study.

Journal: Healthcare (Basel, Switzerland)

Published: April 12, 2026

Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivity.

Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivity.

Journal: Multiple sclerosis and related disorders

Published: March 12, 2026

Gammopathic optic neuritis: a case evolving from visual symptoms to MGUS diagnosis.

Gammopathic optic neuritis: a case evolving from visual symptoms to MGUS diagnosis.

Journal: Acta neurologica Belgica

Published: March 04, 2026

Is there a role of MOG antibodies in idiopathic intracranial hypertension: A comparative analysis with optic neuritis-MOG antibody associated disease.

Is there a role of MOG antibodies in idiopathic intracranial hypertension: A comparative analysis with optic neuritis-MOG antibody associated disease.

Journal: Multiple sclerosis and related disorders

Published: November 05, 2025

Management of MOGAD in an immunosuppressed HIV-positive patient: the first case presenting with alexia without agraphia.

Management of MOGAD in an immunosuppressed HIV-positive patient: the first case presenting with alexia without agraphia.

Journal: Neurocase

Published: November 05, 2025

Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Journal: Journal of neurology

Published: November 04, 2025

Differential Metacognitive Profiles in Relapsing-Remitting and Progressive Multiple Sclerosis: Associations with Fatigue, Cognition, and Perceived Disability.

Differential Metacognitive Profiles in Relapsing-Remitting and Progressive Multiple Sclerosis: Associations with Fatigue, Cognition, and Perceived Disability.

Journal: Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists

Published: September 02, 2025

Corrigendum to "Real-world evidence from Türkiye on cancer risk and treatment exposure in multiple sclerosis: A histopathology-verified, registry-based study" [MSARD, Vol.100, 2025,106547].

Corrigendum to "Real-world evidence from Türkiye on cancer risk and treatment exposure in multiple sclerosis: A histopathology-verified, registry-based study" [MSARD, Vol.100, 2025,106547].

Journal: Multiple sclerosis and related disorders

Published: August 12, 2025

Sexual dysfunction in multiple sclerosis: prevalence, risk factors, and impact on quality of life in a large cohort study.

Sexual dysfunction in multiple sclerosis: prevalence, risk factors, and impact on quality of life in a large cohort study.

Journal: BMC neurology

Published: June 06, 2025

Current Approach to Perioperative Evaluation of Neurological Diseases.

Current Approach to Perioperative Evaluation of Neurological Diseases.

Journal: The neurologist

Published: June 04, 2025

Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD).

Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD).

Journal: Journal of neuroimmunology

Published: May 08, 2025

Showing 1-12 of 66

Last Updated: 09/26/2026